Timolol and Macrocephaly - a phase IV clinical study of FDA data
Summary:
We study 9,652 people who take Timolol (timolol) or have Macrocephaly. No report of Macrocephaly is found in people who take Timolol.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Timolol?
Timolol has active ingredients of timolol. It is often used in glaucoma. eHealthMe is studying from 9,142 Timolol users. Check the latest studies of Timolol.
What is Macrocephaly?
Macrocephaly (a condition in which the head is larger than normal) is found to be associated with 68 drugs and 195 conditions by eHealthMe. Check the latest studies of Macrocephaly.
No report is found.
Do you take Timolol and have Macrocephaly?
- Check whether Macrocephaly is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Timolol:
- Timolol (9,142 reports)
Macrocephaly treatments and more:
- Macrocephaly (510 reports)
How severe was Macrocephaly and when was it recovered:
Expand to all the drugs that have ingredients of timolol:
Browse all side effects of Timolol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Macrocephaly:
Browse all the conditions that are associated with Macrocephaly:
How the study uses the data?
The study uses data from the FDA. It is based on timolol (the active ingredients of Timolol) and Timolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cachexia and drugs of ingredients of prednisone - 3 seconds ago
- Drug interactions of Tylenol W/ Codeine and Metronidazole - 4 seconds ago
- Cefdinir vs. Sulfamethoxazole And Trimethoprim Double Strength, side effect and effectiveness comparison - 5 seconds ago
- Drug interactions of Thiamine Hydrochloride and Lipitor - 5 seconds ago
- Could Melatonin cause Parkinsonian Gait? - 12 seconds ago
- Anaemia and Shunt Occlusion - 15 seconds ago
- Drug interactions of Temsirolimus and Soma - 20 seconds ago
- Drug interactions of Hydroxyzine and Ofev - 22 seconds ago
- Drug interactions of Dexamethasone and Genvoya - 22 seconds ago
- Tamiflu vs. Cephalexin, side effect and effectiveness comparison - 25 seconds ago